Related Experiment Video
Updated: Aug 19, 2025

Protocol to Create Chronic Wounds in Diabetic Mice
Published on: September 25, 2019
[Latest Findings on MicroRNAs in Diabetic Chronic Wounds]
Yi-Xuan Fang1, Li-Hong Chen1, Yan Li1
1Innovation Center for Wound Repair, Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China.
Abstract:
Diabetic chronic wound is one of the most serious complications of diabetes, imposing enormous socioeconomic burdens on diabetic patients, their families, and society due to its refractory nature. MicroRNAs (miRNAs) have emerged as important regulators of various physiological and pathological processes. Abnormalities arise in the regulatory functions of miRNAs in chronic diabetic wounds. Therefore, the modification of miRNAs expression in diabetic wounds is an important channel for the improvement of wound healing. The clinical translation of miRNA-based therapy may become a prospective direction of diabetic wound healing. However, miRNA-based therapy is still in its early stage of development, and actual translation into clinical application will take a long time. Herein, we summarized the latest research findings on miRNAs in diabetic chronic wounds healing.
Insights
MicroRNAs (miRNAs) are key regulators of diabetic wound healing. Modifying miRNA expression shows promise for improving chronic wound outcomes, though clinical applications are still developing.
Area of Science:
- Biomedical Science
- Molecular Biology
- Regenerative Medicine

